DM-2 progresses with hyperinsulinemia secondary to hyperglycemia and resistance develops over time due to the continuous stimulation of insulin receptors, especially in patients with a BMI >30 [24,25]. The gene discussed is INSR; the disease is Hyperinsulinemia.